[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100444342":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":31,"responsibleParty":54,"collaborators":20,"id":57,"slug":20,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":20,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":76,"overallStatus":33,"whyStopped":20,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"MGH Institute of Health Professions","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"CAS Treatment for MV ASD","EXPERIMENTAL","Participants will receive CAS treatment, modified for minimally verbal children with autism",[13],"Behavioral: CAS Treatment for Minimally Verbal Children with Autism",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BEHAVIORAL","CAS Treatment for Minimally Verbal Children with Autism","Treatment involves principles of motor learning embedded in a naturalistic developmental milieu",[9],null,[22,27],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Karen V Chenausky, Ph.D.","CONTACT","617-726-2405","kvchenausky@mghihp.edu",{"name":28,"role":24,"phone":29,"phoneExt":20,"email":30},"Michael Moody","617-643-4658","mjmoody@partners.org",[32],{"facility":5,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"RECRUITING","Boston","Massachusetts","02129","United States","US",{"type":40,"coordinates":41},"Point",[42,43],-71.05977,42.35843,{"lat":43,"lon":42},[46,49,51],{"name":47,"role":24,"phone":25,"phoneExt":20,"email":48},"Steve Meyer","ihpspanlab@mghb.org",{"name":50,"role":24,"phone":20,"phoneExt":20,"email":26},"Karen Chenausky, PhD",{"name":52,"role":53,"phone":20,"phoneExt":20,"email":20},"Karen V Chenausky, PhD","PRINCIPAL_INVESTIGATOR",{"type":53,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Karen Chenausky, Ph.D., CCC-SLP","Assistant Professor","100444342",false,"NCT05066178","Speech Treatment for Minimally Verbal Children With ASD and CAS","TxMVASD+CAS","Inclusion Criteria:\n\n* Meets criteria for Autism Spectrum Disorder\n* Able to correctly repeat at least 2 syllables\n* Meets criteria for Childhood Apraxia of Speech\n* Lives in an environment where child is exposed to English at least 50% of the time\n\nExclusion Criteria:\n\n* Poorly controlled seizures\n* Factors such as blindness or deafness that contribute to minimally verbal status\n* Lives in an environment where English is not spoken at least 50% of the time\n* Child experiences behavioral challenges that preclude participation in the study","ALL","5 Years","18 Years",{"count":67,"type":68},20,"ESTIMATED","INTERVENTIONAL",[71],"NA","Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning. This study tests whether CAS-specific treatment, appropriately modified for minimally verbal children with autism, improves their speech.",[74,75],"Developmental Verbal Dyspraxia","Autism Spectrum Disorder",[77,78,79,80],"childhood apraxia of speech","autism","motor speech disorder","speech development","2026-03-25",{"date":83,"type":84},"2026-03-30","ACTUAL",{"date":86,"type":84},"2024-05-01",{"date":88,"type":68},"2030-11-30",{"name":5,"class":6},1]